These findings suggest that overproduction of MMP-9 along with oxidative stress and inflammation is implicated in asthma exacerbation and that measurements of these biomarkers (for oxidative stress, inflammation, and remodeling) in blood can be a valid index in the management of asthma to assess the status of oxidative stress, inflammation, and remodeling. The gene discussed is MMP9; the disease is asthma.